Cancer Immunotherapy Column

Harnessing the innate immune system to treat cancer: enhancement of antibody-dependent cellular cytotoxicity with anti-CD137 Ab

Posted on 2017-08-11 14:24:36

Atsushi Yonezawa1,2, Cariad Chester1,3, Narendiran Rajasekaran1, Holbrook E. Kohrt1

Immunotherapy of patients with metastatic melanoma

Posted on 2017-07-21 15:21:33

Zhe Yu1, Lu Si2

Next generation approaches for tumor vaccination

Posted on 2017-07-21 15:19:51

Anand Patel1, Howard L. Kaufman1, Mary L. Disis2

Advances in evidence-based cancer adoptive cell therapy

Posted on 2017-07-21 15:17:26

Chunlei Ge1, Ruilei Li1, Xin Song1, Shukui Qin2

Immune checkpoint inhibitors in lung cancer: current status and future directions

Posted on 2017-07-21 15:11:34

Yun Fan, Weimin Mao

1 - 5 of 5 Items

Disclosure:
The series “Cancer Immunotherapy Column” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Bernard Fox, Shukui Qin, Wenru Song and Jon Wigginton served as the unpaid Guest Editors for the series.